Rituxan and blood lactate dehydrogenase increased Patient Reports February 11, 2012

Rituxan Side Effects Report #5269137-1
Rituxan side effect was reported by a Health Professional from UNITED STATES on Mar 02, 2007. Female patient, 41 years of age, weighting 123.5 lb, was diagnosed with rheumatoid arthritis  and was treated with Rituxan. After drug was administered, patient experienced the following side effects: blood alkaline phosphatase increased, blood chloride decreased, blood lactate dehydrogenase increased, neutrophil count increased, platelet count increased, viral myocarditis, white blood cell count increased. Rituxan dosage: 1000 MG, DAYS 1+15, INTRAVENOUS. During the same period patient was treated with METHYLPREDNISOLONE, PREDNISONE, METHOTREXATE, NAPROXEN, FOLIC ACID, TYLENOL #, LORTAB. Patient died on 09/21/2006.

Rituxan Side Effects Report #4701096-X
Rituxan side effect was reported by a Physician from on June 10, 2005. Female patient, 77 years of age, weighting 92.59 lb, was diagnosed with non-hodgkin's lymphoma and was treated with Rituxan. After drug was administered, patient experienced the following side effects: anaemia, blood alkaline phosphatase increased, blood lactate dehydrogenase increased, blood pressure , leukopenia, pruritus. Rituxan dosage: 500 MG, IV DRIP. During the same period patient was treated with CYCLOPHOSPHAMIDE, DOXORUBICIN, VINCRISTINE, PREDNISONE, VENA, CALONAL, MAGNESIUM OXIDE, MUCOSTA. Patient recovered.

Rituxan Side Effects Report #4704785-6
Rituxan side effect was reported by a Physician from on June 16, 2005. Female patient, 77 years of age, weighting 92.59 lb, was diagnosed with non-hodgkin's lymphoma and was treated with Rituxan. After drug was administered, patient experienced the following side effects: anaemia, basophil percentage increased, blood alkaline phosphatase increased, blood lactate dehydrogenase increased, blood pressure abnormal, granulocyte count decreased, neutrophil percentage decreased, pruritus, white blood cell count decreased. Rituxan dosage: 500 MG, IV DRIP. During the same period patient was treated with CYCLOPHOSPHAMIDE, DOXORUBICIN, VINCRISTINE, PREDNISONE, VENA, CALONAL, MAGNESIUM OXIDE, MUCOSTA. Patient recovered.

Rituxan Side Effects Report #4710629-9
Rituxan side effect was reported by a Physician from JAPAN on June 16, 2005. Female patient, 77 years of age, weighting 92.60 lb, was diagnosed with non-hodgkin's lymphoma and was treated with Rituxan. After drug was administered, patient experienced the following side effects: anaemia, basophil percentage increased, blood alkaline phosphatase increased, blood lactate dehydrogenase increased, blood pressure abnormal, granulocyte count decreased, infusion related reaction, neutrophil percentage decreased, pruritus. Rituxan dosage: 500 MG IV DRIP. During the same period patient was treated with CYCLOPHOSPHAMIDE, DOXORUBICIN, VINCRISTINE, PREDNISONE, VENA, CALONAL, MAGNESIUM OXIDE, MUCOSTA. Patient recovered.


Rituxan Side Effects Report #4724561-8
Rituxan side effect was reported by a Physician from JAPAN on July 11, 2005. Female patient, 77 years of age, weighting 92.60 lb, was diagnosed with non-hodgkin's lymphoma and was treated with Rituxan. After drug was administered, patient experienced the following side effects: anaemia, blood alkaline phosphatase increased, blood lactate dehydrogenase increased, blood pressure abnormal, granulocyte count decreased, pruritus, white blood cell count decreased. Rituxan dosage: 500 MG IV DRIP. During the same period patient was treated with CYCLOPHOSPHAMIDE, VINCRISTINE, PREDNISONE, VENA, CALONAL, MAGNESIUM OXIDE, MUCOSTA, LECICARBON. Patient recovered.

Rituxan Side Effects Report #4828881-8
Rituxan side effect was reported by a Physician from JAPAN on Oct 27, 2005. Male patient, 77 years of age, was diagnosed with non-hodgkin's lymphoma and was treated with Rituxan. After drug was administered, patient experienced the following side effects: blood albumin decreased, blood calcium decreased, blood calcium increased, blood lactate dehydrogenase increased, blood potassium decreased, blood sodium increased, clostridium colitis, disseminated intravascular coagulation, haemoglobin decreased. Rituxan dosage: 500 MG, INTRAVENOUS. During the same period patient was treated with ADRIAMYCIN PFS, CYCLOPHOSPHAMIDE, ONCOVIN, PREDONINE, MEROPENEM, MINOCYCLINE HYDROCHLORIDE, BRUFEN, POLARAMINE. Patient died on 03/16/2004.

Rituxan Side Effects Report #4839893-2
Rituxan side effect was reported by a Physician from JAPAN on Nov 14, 2005. Male patient, 77 years of age, was diagnosed with non-hodgkin's lymphoma and was treated with Rituxan. After drug was administered, patient experienced the following side effects: blood albumin decreased, blood calcium increased, blood creatinine increased, blood lactate dehydrogenase increased, blood potassium decreased, blood urea increased, clostridium colitis, disseminated intravascular coagulation, haemoglobin decreased. Rituxan dosage: 500 MG, INTRAVENOUS. During the same period patient was treated with ADRIAMYCIN PFS, CYCLOPHOSPHAMIDE, ONCOVIN, PREDONINE, MEROPENEM, MINOCYCLINE HYDROCHLORIDE, BRUFEN, POLARAMINE. Patient died on 03/16/2004.

Rituxan Side Effects Report #4835746-4
Rituxan side effect was reported by a Physician from JAPAN on Nov 04, 2005. Female patient, 76 years of age, weighting 116.8 lb, was diagnosed with non-hodgkin's lymphoma and was treated with Rituxan. After drug was administered, patient experienced the following side effects: aspartate aminotransferase increased, blood lactate dehydrogenase increased, coronary artery occlusion, coronary artery thrombosis, myocardial infarction. Rituxan dosage: 500 MG, IV DRIP. Patient was hospitalized. Patient recovered.

Rituxan Side Effects Report #4810041-8
Rituxan side effect was reported by a Physician from JAPAN on Oct 11, 2005. Male patient, 70 years of age, weighting 110.2 lb, was diagnosed with non-hodgkin's lymphoma and was treated with Rituxan. After drug was administered, patient experienced the following side effects: blood creatinine increased, blood lactate dehydrogenase increased, blood potassium increased, blood urea increased, haemoglobin decreased, lymphocyte percentage increased, neutrophil percentage decreased, platelet count decreased, red blood cell count decreased. Rituxan dosage: 530 MG, QD. During the same period patient was treated with CYCLOPHOSPHAMIDE, DOXORUBICIN HYDROCHLORIDE, VINCRISTINE, PREDNISONE, GRANISETRON, ACETAMINOPHEN, CHLORPHENIRAMINE MALEATE, PANIPENEM. Patient recovered.


Rituxan Side Effects Report #4810392-7
Rituxan side effect was reported by a Physician from JAPAN on Oct 11, 2005. Male patient, 70 years of age, weighting 110.2 lb, was diagnosed with non-hodgkin's lymphoma and was treated with Rituxan. After drug was administered, patient experienced the following side effects: blood creatine increased, blood lactate dehydrogenase increased, blood urea increased, haemoglobin decreased, lymphocyte percentage decreased, lymphocyte percentage increased, neutrophil percentage decreased, platelet count decreased, red blood cell count decreased. Rituxan dosage: 530 MG, QD,. During the same period patient was treated with CYCLOPHOSPHAMIDE, DOXORUBICIN HYDROCHLORIDE, VINCRISTINE, PREDNISONE, GRANISETRON, ACETAMINOPHEN, CHLORPHENIRAMINE MALEATE, PANIPENEM. Patient recovered.

Rituxan Side Effects Report #4811725-8
Rituxan side effect was reported by a Physician from JAPAN on Oct 11, 2005. Male patient, 70 years of age, weighting 110.2 lb, was diagnosed with non-hodgkin's lymphoma and was treated with Rituxan. After drug was administered, patient experienced the following side effects: abdominal pain , blood lactate dehydrogenase increased, cough, haemoglobin decreased, hypokalaemia, neutrophil percentage decreased, platelet count decreased, pleurisy, pyrexia. Rituxan dosage: 530 MG, INTRAVENOUS. During the same period patient was treated with CYCLOPHOSPHAMIDE, DOXORUBICIN HYDROCHLORIDE, VINCRISTINE SULPHATE, PREDNISOLONE ACETATE, DEXAMETHASONE PHOSPHATE, GRANISETRON, AMIKACIN SULPHATE, AMPHOTERICIN B. Patient recovered.

Rituxan Side Effects Report #4842684-X
Rituxan side effect was reported by a Health Professional from UNITED STATES on Nov 16, 2005. Male patient, 69 years of age, weighting 177.5 lb, was diagnosed with non-hodgkin's lymphoma and was treated with Rituxan. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, alveolitis allergic, amyloidoma, aspartate aminotransferase increased, blood lactate dehydrogenase increased, candidiasis, cd4 lymphocytes decreased, cryptogenic organizing pneumonia. Rituxan dosage: 375 MG/M2, QD, INTRAVENOUS. During the same period patient was treated with FLUDARABINE PHOSPHATE, LEVOFLOXACIN. Patient was hospitalized. Patient recovered.

Rituxan Side Effects Report #4933968-5
Rituxan side effect was reported by a Health Professional from UNITED STATES on Mar 01, 2006. Male patient, 69 years of age, weighting 177.5 lb, was diagnosed with non-hodgkin's lymphoma and was treated with Rituxan. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, alveolitis allergic, amyloidoma, aspartate aminotransferase increased, blood lactate dehydrogenase increased, candidiasis, cd4 lymphocytes decreased, condition aggravated, cough. Rituxan dosage: 375 MG/M2, QD, INTRAVENOUS. During the same period patient was treated with FLUDARABINE PHOSPHATE, LEVOFLOXACIN. Patient was hospitalized. Patient recovered.

Rituxan Side Effects Report #4724607-7
Rituxan side effect was reported by a Physician from JAPAN on July 08, 2005. Male patient, 64 years of age, was diagnosed with non-hodgkin's lymphoma and was treated with Rituxan. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, blood alkaline phosphatase increased, blood lactate dehydrogenase increased, white blood cell count decreased. Rituxan dosage: 375 MG/M2, INTRAVENOUS. During the same period patient was treated with CYCLOPHOSPHAMIDE, VINCRISTINE, DOXORUBICIN, PREDNISONE. Patient recovered.


Rituxan Side Effects Report #4759315-X
Rituxan side effect was reported by a Physician from JAPAN on Aug 26, 2005. Male patient, 64 years of age, was diagnosed with non-hodgkin's lymphoma and was treated with Rituxan. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, blood alkaline phosphatase increased, blood lactate dehydrogenase increased, hepatic function abnormal, white blood cell count decreased. Rituxan dosage: 375 MG/M2, INTRAVENOUS. During the same period patient was treated with CYCLOPHOSPHAMIDE, VINCRISTINE, DOXORUBICIN, PREDNISONE. Patient recovered.

Rituxan Side Effects Report #4899516-3
Rituxan side effect was reported by a Health Professional from JAPAN on Jan 18, 2006. Female patient, 61 years of age, was diagnosed with non-hodgkin's lymphoma and was treated with Rituxan. After drug was administered, patient experienced the following side effects: bacterial infection , blood lactate dehydrogenase increased, lymphocyte count increased, neutrophil count increased, pneumocystis jiroveci pneumonia, respiratory failure, white blood cell count decreased. Rituxan dosage: 400MG, INTRAVENOUS. During the same period patient was treated with CYCLOPHOSPHAMIDE, DOXORUBICIN, VINCRISTINE, PREDNISONE, ZESULIN, SPIROPENT, THEOPHYLLINE. Patient died on 08/11/2002.

Rituxan Side Effects Report #4686707-X
Rituxan side effect was reported by a Physician from on May 25, 2005. Female patient, 59 years of age, was diagnosed with non-hodgkin's lymphoma and was treated with Rituxan. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, blood lactate dehydrogenase increased, liver disorder, platelet count decreased. Rituxan dosage: 500 MG, 1/WEEK, INTRAVENOUS. During the same period patient was treated with RESTAMIN, IBUPROFEN, MUCOSTA, FAMOTIDINE, MAGNESIUM OXIDE. Patient recovered.

Rituxan Side Effects Report #4710573-7
Rituxan side effect was reported by a Physician from JAPAN on June 23, 2005. Female patient, 59 years of age, was diagnosed with non-hodgkin's lymphoma and was treated with Rituxan. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, blood lactate dehydrogenase increased, liver disorder, platelet count decreased. Rituxan dosage: 500 MG, 1/WEEK, INTRAVENOUS. During the same period patient was treated with RESTAMIN, IBUPROFEN, MUCOSTA, FAMOTIDINE, MAGNESIUM OXIDE. Patient recovered.

Rituxan Side Effects Report #4710494-X
Rituxan side effect was reported by a Physician from JAPAN on June 22, 2005. Female patient, 57 years of age, weighting 88.18 lb, was diagnosed with non-hodgkin's lymphoma and was treated with Rituxan. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, blood alkaline phosphatase increased, blood lactate dehydrogenase increased, hepatic function abnormal, laboratory test abnormal, pancytopenia, pyrexia. Rituxan dosage: unknown. During the same period patient was treated with PIRARUBICIN HYDROCHLORIDE, ENDOXAN, ONCOVIN, PREDNISOLONE, LOXONIN, POLARAMINE. Patient recovered.


Rituxan Side Effects Report #4745105-0
Rituxan side effect was reported by a Physician from JAPAN on Aug 02, 2005. Female patient, 57 years of age, weighting 88.18 lb, was diagnosed with non-hodgkin's lymphoma and was treated with Rituxan. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, blood alkaline phosphatase increased, blood lactate dehydrogenase increased, hepatic function abnormal, pancytopenia, pyrexia. Rituxan dosage: unknown. During the same period patient was treated with THERARUBICIN, CYCLOPHOSPHAMIDE, ONCOVIN, PREDONINE, LOXONIN, POLARAMINE. Patient recovered.

Rituxan Side Effects Report #4699183-8
Rituxan side effect was reported by a Physician from on June 07, 2005. Female patient, 54 years of age, weighting 121.3 lb, was diagnosed with non-hodgkin's lymphoma and was treated with Rituxan. After drug was administered, patient experienced the following side effects: blood lactate dehydrogenase increased, c-reactive protein increased, chills, cyanosis, peripheral coldness. Rituxan dosage: 600 MG, INTRAVENOUS. During the same period patient was treated with IBRUFEN, ATARAX. Patient recovered.

Rituxan Side Effects Report #4796328-6
Rituxan side effect was reported by a Physician from JAPAN on Sept 28, 2005. Male patient, 54 years of age, was diagnosed with non-hodgkin's lymphoma and was treated with Rituxan. After drug was administered, patient experienced the following side effects: blood lactate dehydrogenase increased, blood potassium decreased, c-reactive protein increased, hypercalcaemia, neutrophil count decreased, neutrophil percentage increased, platelet count decreased, white blood cell count decreased. Rituxan dosage: 600 MG, 600 MG, INTRAVENOUS; 600 MG; 600 MG. During the same period patient was treated with CYTARABINE, CISPLATIN, IBUPROFEN, DIPHENHYDRAMINE, LAMIVUDINE. Patient was hospitalized. Patient recovered.

Rituxan Side Effects Report #4940900-7
Rituxan side effect was reported by a Physician from JAPAN on Mar 06, 2006. Male patient, 54 years of age, was diagnosed with non-hodgkin's lymphoma and was treated with Rituxan. After drug was administered, patient experienced the following side effects: blood lactate dehydrogenase increased, blood potassium decreased, hypercalcaemia, neutrophil count decreased, platelet count decreased, white blood cell count decreased. Rituxan dosage: 600 MG INTRAVENOUS. During the same period patient was treated with CYTARABINE, CISPLATIN, IBUPROFEN, DIPHENHYDRAMINE, LAMIVUDINE. Patient was hospitalized. Patient recovered.

Rituxan Side Effects Report #4688435-3
Rituxan side effect was reported by a Physician from on May 25, 2005. Male patient, 50 years of age, weighting 138.9 lb, was diagnosed with non-hodgkin's lymphoma and was treated with Rituxan. After drug was administered, patient experienced the following side effects: blood lactate dehydrogenase increased, chills, hepatic function abnormal, white blood cell count decreased. Rituxan dosage: 660 MG, 1/MONTH. During the same period patient was treated with CYCLOPHOSPHAMIDE, VINCRISTINE, DOXORUBICIN HYDROCHLORIDE, PREDNISONE, POLARAMINE, IBUPROFEN, ZOFRAN. Patient recovered.


Rituxan Side Effects Report #4698867-5
Rituxan side effect was reported by a Physician from on June 09, 2005. Male patient, 50 years of age, weighting 117.9 lb, was diagnosed with non-hodgkin's lymphoma and was treated with Rituxan. After drug was administered, patient experienced the following side effects: blood lactate dehydrogenase increased, dyspnoea, neutropenia, white blood cell count decreased. Rituxan dosage: 536 MG, IV DRIP. During the same period patient was treated with CARBOPLATIN, DEXAMETHASONE, ETOPOSIDE, IRINOTECAN, CETAPRIL, ADALAT, LASIX, ALDACTONE. Patient was hospitalized. Patient recovered.

Rituxan Side Effects Report #4700712-6
Rituxan side effect was reported by a Physician from on June 09, 2005. Female patient, 47 years of age, was diagnosed with non-hodgkin's lymphoma and was treated with Rituxan. After drug was administered, patient experienced the following side effects: abdominal pain upper, alanine aminotransferase increased, aspartate aminotransferase increased, blood alkaline phosphatase increased, blood lactate dehydrogenase increased, chills, disseminated intravascular coagulation, fatigue, headache . Rituxan dosage: 600 MG, INTRAVENOUS. During the same period patient was treated with SALINE, POLARAMINE, CALONAL, FAMOTIDINE, SELBEX, BIOFERMIN, URALYT. Patient recovered.

Rituxan Side Effects Report #4704616-4
Rituxan side effect was reported by a Physician from on June 16, 2005. Male patient, 37 years of age, weighting 136.7 lb, was diagnosed with non-hodgkin's lymphoma and was treated with Rituxan. After drug was administered, patient experienced the following side effects: abdominal neoplasm, anaemia, blood lactate dehydrogenase increased, condition aggravated, headache , neutrophil percentage decreased, platelet count decreased, protein total decreased, white blood cell count decreased. Rituxan dosage: 700 MG, IV DRIP. During the same period patient was treated with CYCLOPHOSPHAMIDE, DEXAMETHASONE, ETOPOSIDE, CYTARABINE, FILGRASTIM, DOXORUBICIN, VINCRISTINE. Patient recovered.

Rituxan Side Effects Report #4967441-5
Rituxan side effect was reported by a Physician from JAPAN on Mar 22, 2006. Male patient, 75 years of age, weighting 110.2 lb, was diagnosed with lymphoma  and was treated with Rituxan. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, blood alkaline phosphatase increased, blood lactate dehydrogenase increased, c-reactive protein increased, hepatic function abnormal, pneumocystis jiroveci pneumonia, white blood cell count decreased. Rituxan dosage: 550 MG, INTRAVENOUS. During the same period patient was treated with ENDOXAN, ONCOVIN, PREDONINE, PIRARUBICIN, IBUPROFEN, HYDROXYZINE PAMOATE, HYDROCORTISONE SUCCINATE, ZOLPIDEM TARTRATE. Patient recovered.

Rituxan Side Effects Report #4625806-5
Rituxan side effect was reported by a Physician from on Mar 28, 2005. Female patient, 46 years of age, weighting 137.8 lb, was diagnosed with extranodal marginal zone b-cell lymphoma (malt type) and was treated with Rituxan. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, blood alkaline phosphatase increased, blood lactate dehydrogenase increased, liver disorder, urinary tract infection , viral infection , vomiting. Rituxan dosage: 600 MG, INTRAVENOUS. During the same period patient was treated with CHLORPHENIRAMINE MALEATE, ACETAMINOPHEN, LOXOPROFEN. Patient was hospitalized. Patient recovered.


Rituxan Side Effects Report #4704424-4
Rituxan side effect was reported by a Physician from on June 13, 2005. Female patient, 66 years of age, weighting 125.7 lb, was diagnosed with diffuse large b-cell lymphoma and was treated with Rituxan. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, blood alkaline phosphatase increased, blood lactate dehydrogenase increased, neutrophil count decreased, pyrexia, white blood cell count decreased. Rituxan dosage: 585 MG, 1/MONTH, INTRAVENOUS. During the same period patient was treated with CYCLOPHOSPHAMIDE, DOXORUBICIN, VINCRISTINE, PREDNISOLONE PHOSPHATE, IBUPROFEN, POLARAMINE, SAXIZON. Patient recovered.

Rituxan Side Effects Report #4730132-X
Rituxan side effect was reported by a Physician from JAPAN on July 20, 2005. Female patient, 66 years of age, weighting 125.7 lb, was diagnosed with diffuse large b-cell lymphoma and was treated with Rituxan. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, blood alkaline phosphatase increased, blood lactate dehydrogenase increased, neutrophil count decreased, neutrophil percentage increased, pyrexia, white blood cell count decreased. Rituxan dosage: 585 MG, 1/MONTH, INTRAVENOUS. During the same period patient was treated with CYCLOPHOSPHAMIDE, DOXORUBICIN, VINCRISTINE, PREDNISOLONE SUCCINATE, IBUPROFEN, POLARAMINE, SAXIZON. Patient recovered.

Rituxan Side Effects Report #4745084-6
Rituxan side effect was reported by a Physician from JAPAN on Aug 03, 2005. Female patient, 66 years of age, weighting 125.7 lb, was diagnosed with diffuse large b-cell lymphoma and was treated with Rituxan. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, blood alkaline phosphatase increased, blood lactate dehydrogenase increased, neutrophil count decreased, pyrexia, white blood cell count decreased. Rituxan dosage: 585 MG, 1/MONTH, INTRAVENOUS. During the same period patient was treated with CYCLOPHOSPHAMIDE, DOXORUBICIN HYDROCHLORIDE, ONCOVIN, PREDONINE, IBUPROFEN, POLARAMINE, SAXIZON, MAGNESIUM OXIDE. Patient recovered.

Rituxan Side Effects Report #4562915-3
Rituxan side effect was reported by a Health Professional from on Jan 14, 2005. Female patient, 68 years of age, was diagnosed with b-cell lymphoma and was treated with Rituxan. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, anuria, aspartate aminotransferase increased, blood bilirubin increased, blood lactate dehydrogenase increased, blood pressure decreased, blood urea increased, cardiac failure, haemosiderosis. Rituxan dosage: 500 MG 2/MONTH INTRAVENOUS. During the same period patient was treated with LEVOTHYROXIN, ANTIFUNGAL, DOPAMINE, GRANISETRON, DOBUTAMINE, DEXAMETHASONE, IMIPENEM. Patient died on 07/16/2003.

Rituxan Side Effects Report #4562917-7
Rituxan side effect was reported by a Health Professional from on Jan 14, 2005. Female patient, 68 years of age, was diagnosed with b-cell lymphoma and was treated with Rituxan. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, anuria, aspartate aminotransferase increased, blood bilirubin increased, blood lactate dehydrogenase increased, blood pressure decreased, cardiac failure, condition aggravated, hepatic function abnormal. Rituxan dosage: 500 MG X2 INTRAVENOUS. During the same period patient was treated with COLDREX, LEVOTHYROXIN, FAMOTIDINE, SULFAMETHOXAZOLE, DOPAMINE, GRANISETRON, DEXAMETHASONE, ANTIFUNGAL. Patient died on 07/16/2003.


Rituxan Side Effects Report #4825224-0
Rituxan side effect was reported by a Health Professional from JAPAN on Oct 27, 2005. Female patient, 43 years of age, weighting 105.8 lb, was diagnosed with b-cell lymphoma and was treated with Rituxan. After drug was administered, patient experienced the following side effects: blood lactate dehydrogenase increased, haemoglobin decreased, neutropenia, peritoneal perforation, peritonitis, platelet count decreased, white blood cell count decreased. Rituxan dosage: 545.62 MG, SINGLE, INTRAVENOUS. During the same period patient was treated with VINCRISTINE, DOXORUBICIN, ETOPOSIDE, CYCLOPHOSPHAMIDE, PREDNISONE, ACETAMINOPHEN, CHLORPHENIRAMINE MALEATE. Patient recovered.

Rituxan Side Effects Report #5138748-6
Rituxan side effect was reported by a Pharmacist from UNITED STATES on Oct 26, 2006. Male patient, weighting 230.8 lb, was treated with Rituxan. After drug was administered, patient experienced the following side effects: blood glucose decreased, blood lactate dehydrogenase increased, bradycardia, cardio-respiratory arrest, chest pain , convulsion, feeling cold, hypotension, infusion related reaction. Rituxan dosage: 840 MG IN 500 ML NS ONCE IV DRIP. Patient was hospitalized. Patient died on 07/20/2006.